Report cover image

Organ Preservation Solutions Market, By Solution Type (Viaspan, Custodiol HTK, Renograf, Hypothermosol, Perfadex, Lifor, HBS Solution, siRNA Transplant Solutions, Others), By Technique Type (Hypothermic Perfusion Preservation, Static Cold Storage, Others)

Publisher Coherent Market Insights
Published May 31, 2022
Length 181 Pages
SKU # CMI17212538

Description

Organ Preservation Solutions Market, By Solution Type (Viaspan, Custodiol HTK, Renograf, Hypothermosol, Perfadex, Lifor, HBS Solution, siRNA Transplant Solutions, Others), By Technique Type (Hypothermic Perfusion Preservation, Static Cold Storage, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Organ preservation involves removal of organs from the bodies, which are then stored for transplantation. Organ preservation systems are exclusively prepared and maintained according to the biological environment (temperature and oxygen) needed to store particular organs. Different body organs require specific and suitable storage conditions to maintain their anatomical and physiological processes. Important parameters in organ preservation include delivering of high quality organs to the donors, matching the patient and organ suitability, and restart of life of the organs and sustaining functions after the transplantation. Organ transplantation process starts with removing the needed organ from the donor body, then the organ is stored and transported.
Restraints of the Global Organ Preservation Solutions Market
Major factors hampering the growth of the organ preservation solutions market during the forecast period constitutes of advent of stem cells, and high costs.
Key features of the study:
This report provides in-depth analysis of the global organ preservation solutions market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021, as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
It profiles leading players in the global organ preservation solutions market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Dr. Franz Köhler Chemie GmbH, BioLife Solutions, XVIVO Perfusion AB, Bristol-Myers Squibb, Inc., and ToleroTech, Inc., Lifeline Scientific, Preservation Solutions Inc., Claris Injectables Limited, 21st Century Medicine, Paragonix Technologies Inc., BioTime, Inc. CryoLife, Inc., and Dr. Franz Köhler Chemie GmbH.
Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
The global organ preservation solutions market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.
Detailed Segmentation
Global Organ Preservation Solutions Market, By Solution Type:
Viaspan
Custodiol HTK
Renograf
Hypothermosol
Perfadex
Lifor
HBS Solution
siRNA Transplant Solutions
Others
Global Organ Preservation Solutions Market, By Technique Type:
Hypothermic Perfusion Preservation
Static Cold Storage
Others
Global Organ Preservation Solutions Market, By Geography:
North America
By Solution Type
Viaspan
Custodiol HTK
Renograf
Hypothermosol
Perfadex
Lifor
HBS Solution
siRNA Transplant Solutions
Others
By Technique Type
Hypothermic Perfusion Preservation
Static Cold Storage
Others
By Country:
U.S.
Canada
Europe
By Solution Type
Viaspan
Custodiol HTK
Renograf
Hypothermosol
Perfadex
Lifor
HBS Solution
siRNA Transplant Solutions
Others
By Technique Type
Hypothermic Perfusion Preservation
Static Cold Storage
Others
By Country:
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
By Solution Type
Viaspan
Custodiol HTK
Renograf
Hypothermosol
Perfadex
Lifor
HBS Solution
siRNA Transplant Solutions
Others
By Technique Type
Hypothermic Perfusion Preservation
Static Cold Storage
Others
By Country:
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
By Solution Type
Viaspan
Custodiol HTK
Renograf
Hypothermosol
Perfadex
Lifor
HBS Solution
siRNA Transplant Solutions
Others
By Technique Type
Hypothermic Perfusion Preservation
Static Cold Storage
Others
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Middle East:
By Solution Type
Viaspan
Custodiol HTK
Renograf
Hypothermosol
Perfadex
Lifor
HBS Solution
siRNA Transplant Solutions
Others
By Technique Type
Hypothermic Perfusion Preservation
Static Cold Storage
Others
By Country:
GCC
Israel
Rest of Middle East
Africa
By Solution Type
Viaspan
Custodiol HTK
Renograf
Hypothermosol
Perfadex
Lifor
HBS Solution
siRNA Transplant Solutions
Others
By Technique Type
Hypothermic Perfusion Preservation
Static Cold Storage
Others
By Country/Region:
Central Africa
South Africa
North Africa
Company Profiles
Teva Pharmaceutical Industries Ltd.*
Company Overview
Product Portfolio
Financial Performance
Key Strategies
Recent Developments
Dr. Franz Köhler Chemie GmbH
BioLife Solutions
XVIVO Perfusion AB
Bristol-Myers Squibb, Inc.
ToleroTech, Inc.
Lifeline Scientific
Preservation Solutions Inc.
Claris Injectables Limited
21st Century Medicine
Paragonix Technologies Inc.
BioTime, Inc.
CryoLife, Inc.
“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

181 Pages
1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Solution Type
Market Snippet, By Technique Type
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Key Developments
Regulatory Scenario
PEST Analysis
COVID-19 Impact Analysis
4. Global Organ Preservation Solutions Market, By Solution Type, 2017 - 2028 (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
Viaspan
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
Custodiol HTK
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
Renograf
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
Hypothermosol
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
Perfadex
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
Lifor
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
HBS Solution
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
siRNA
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Segment Trends
5. Global Organ Preservation Solutions Market, By Technique Type, 2017 - 2028 (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
Hypothermic Perfusion Preservation
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Static Cold Storage
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
6. Global Organ Preservation Solutions Market, By End User, 2017 - 2028 (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
Public/Private healthcare institutions
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Physicians
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Healthcare workers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Individuals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
7. Global Organ Preservation Solutions Market, By Regions, 2017 - 2028 (US$ Mn)
Introduction
Market Share Analysis, 2022 and 2028 (%)
Y-o-Y Growth Analysis, 2017 - 2028
Segment Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
North Africa
Central Africa
South Africa
8. Competitive Landscape
Company Profiles
Teva Pharmaceutical Industries Ltd.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Dr. Franz Köhler Chemie GmbH
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
BioLife Solutions
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
XVIVO Perfusion AB
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Bristol-Myers Squibb, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
ToleroTech, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Lifeline Scientific
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Preservation Solutions Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Claris Injectables Limited
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
21st Century Medicine
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
Paragonix Technologies Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
BioTime, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
CryoLife, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Strategies
9. Section
References
Research Methodology
About us and Sales Contact
*Browse 34 market data tables and 25 figures on “Organ Preservation Solutions Market – Global forecast to 2028.

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us